Katrina Morris - Concepedia

Author

Katrina Morris

University of Manchester ORCID

Also Known As

K. A. Morris, K. Morris, Katrina A Morris, Katrina A. Morris, Katrina KM Morris, Katrina Morris

Publications

563

Citations

H-Index

Concepts

All Affiliations

University of Manchester Johns Hopkins University National Cancer Institute John Radcliffe Hospital Massachusetts General Hospital

About

Katrina Morris is an author at University of Manchester specializing in neuropathology, neurology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	70
2	Neurology	2	2	70
3	Social Sciences	1	1	20
4	Neuroscience	1	1	20
5	Pathology	1	1	50

Katrina Morris

Publications

450

Citations

H-Index

Page 1

	Year	Citations
Current whole-body MRI applications in the neurofibromatoses Shivani Ahlawat, Laura M. Fayad, Muhammad Shayan Khan, Neurology	2016	85
Bevacizumab in neurofibromatosis type 2 (NF2) related vestibular schwannomas: a nationally coordinated approach to delivery and prospective evaluation Katrina Morris, John F. Golding, Patrick Axon, Neuro-Oncology Practice	2016	84
Toxicity profile of bevacizumab in the UK Neurofibromatosis type 2 cohort Katrina Morris, John F. Golding, Claire Blesing, Journal of Neuro-Oncology Neuro-oncologyToxicity ProfileUk NeurofibromatosisPathologyNeurology	2016	50
Patient-reported outcomes of pain and physical functioning in neurofibromatosis clinical trials Pamela L. Wolters, Staci Martin, Vanessa L. Merker, Neurology	2016	45
Acoustic neuroma (schwannoma) surgery 1978–1990 J. E. M. Dutton, Richard Ramsden, R. H. Lye, The Journal of Laryngology & Otology	1991	33
The response of spinal cord ependymomas to bevacizumab in patients with neurofibromatosis Type 2 Katrina Morris, Shazia Afridi, D. Gareth Evans, Journal of Neurosurgery Spine	2016	30
Snack and Relax® Perpetua Markwell, Barbara J. Polivka, Katrina Morris, Journal of Holistic Nursing	2015	28
Current status and recommendations for biomarkers and biobanking in neurofibromatosis C. Oliver Hanemann, Jaishri O. Blakeley, Fabio P. Nunes, Neurology	2016	22
Chimeric Antigen Receptor T-Cell Therapy in the Outpatient Setting: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy Olalekan O. Oluwole, Bhagirathbhai Dholaria, Tristan Knight, Transplantation and Cellular Therapy	2023	21
Neurocognitive outcomes in neurofibromatosis clinical trials Karin S. Walsh, Jennifer Janusz, Pamela L. Wolters, Neurology Cognitive EndpointsNeuropsychologyClinical NeurologyNeuropsychiatryPerformance Measures	2016	20

Page 1